Bispecific antibody News and Research

RSS
NIH awards MacroGenics $9.8 million grant for three projects

NIH awards MacroGenics $9.8 million grant for three projects

TF12 antibody targets EGP-1 expressed in epithelial cancer: Immunomedics

TF12 antibody targets EGP-1 expressed in epithelial cancer: Immunomedics

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

Immunomedics reports encouraging results from TF2 Phase I studies for colorectal cancer

Immunomedics reports encouraging results from TF2 Phase I studies for colorectal cancer

Fox Chase Cancer Center announces first-in-human bi-specific HER2/HER3 pathway targeting antibody

Fox Chase Cancer Center announces first-in-human bi-specific HER2/HER3 pathway targeting antibody

Genmab reports revenues of DKK 107M for first-quarter 2010

Genmab reports revenues of DKK 107M for first-quarter 2010

Genmab introduces new pre-clinical antibody program and novel bispecific antibody technology

Genmab introduces new pre-clinical antibody program and novel bispecific antibody technology

Pre-clinical data on MM-121 and MM-111 to be presented at AACR 2010

Pre-clinical data on MM-121 and MM-111 to be presented at AACR 2010

MedImmune to present ten abstracts at American Association for Cancer Research meeting

MedImmune to present ten abstracts at American Association for Cancer Research meeting

New peptide-based cancer vaccine tested in genital cancer patients

New peptide-based cancer vaccine tested in genital cancer patients

Cancer fighting technology uses UV light to attack tumours

Cancer fighting technology uses UV light to attack tumours

Emerging cancer therapies and novel targets

Emerging cancer therapies and novel targets